Search Results

CSL Behring provides protein-based and recombinant therapies for bleeding disorders, immune deficiencies, hereditary angioedema and Alpha 1 antitrypsin deficiency, among others.

https://www.cslbehring.com/products/global-products-list

CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.

https://www.cslbehring.com/products

CSL Behring is a global biotech leader in the development of new therapies for serious and rare disease.

https://www.cslbehring.com/r-and-d/product-pipeline

CSL Behring supports Material Transfer (MT) of post-approval product in limited quantity via the Material Transfer Agreement (MTA).

https://www.cslbehring.com/r-and-d/awards-and-grants/material-transfers

CSL Behring is the source for all of your fibrinogen and thrombin further manufacturing needs.

https://www.cslbehring.com/contact/thrombin-fibrinogen-inquiries

CSL Behring provides protein-based therapies for bleeding disorders, critical care, pulmonary disease, and other rare illnesses.

https://www.cslbehring.com/products/patents

CSL Behring offers an array of therapeutic support programs. We are here to help. Learn more today.

https://www.cslbehring.com/patients/support-and-assistance

CSL Behring's only US manufacturing plant is located in Kankakee, Illinois and employs more than 1,400 people.

https://www.cslbehring.com/our-company/kankakee-manufacturing-site

We support Investigator-Initiated Studies (IIS) that advance scientific knowledge of CSL Behring products and the diseases they are designed to treat.

https://www.cslbehring.com/r-and-d/awards-and-grants/investigator-initiated-studies

Social Media Community Guidelines for CSL Behring Corporate Channels

https://www.cslbehring.com/social-guidelines